KDM6B induces demethylation of H3K27me3 in MFN1 to modulate aberrant mitophagy in sepsis-induced acute lung injury
Authors:
Open Access
- 8 December 2025
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 43339
Abstract
Acute lung injury (ALI) commonly occurs as a complication of sepsis, significantly increasing mortality rates in septic patients. Macrophages play a critical role in sepsis pathogenesis. KDM6B, a histone demethylase, has been reported to regulate macrophage death in ALI. In this study, we investigated the impact of KDM6B on macrophage processes during sepsis-induced ALI and elucidated the underlying molecular mechanisms. A cecal ligation and puncture (CLP)-induced septic mouse model was established to assess KDM6B's effects on lung injury severity and survival outcomes. Raw264.7 macrophages were stimulated with lipopolysaccharide (LPS) and interferon-γ (IFN-γ) to create an in vitro cell injury model, followed by flow cytometric analysis for apoptosis detection, DCFH-DA staining for oxidative stress assessment, and western blot analysis for mitophagy evaluation. Chromatin immunoprecipitation assays were performed to determine KDM6B's regulatory effects on histone H3 lysine 27 (H3K27) methylation status in the MFN1 promoter region. Results demonstrated upregulated KDM6B expression in CLP-induced septic mouse lungs. In vitro experiments revealed that KDM6B knockdown significantly suppressed LPS/IFN-γ-induced apoptosis while promoting mitophagy in macrophages. In vivo analyses showed that KDM6B suppression attenuated lung injury severity, inflammatory responses, and improved survival rates in septic mice. Mechanistically, KDM6B knockdown increased H3K27me3 levels, reduced MFN1 expression, and increased H3K27me3 enrichment specifically at the MFN1 promoter region. These findings demonstrate that KDM6B silencing facilitates H3K27me3 modification at the MFN1 promoter to inhibit its transcription, subsequently suppressing macrophage apoptosis and promoting mitophagy, which collectively mitigates sepsis-induced ALI progression.Keywords
This publication has 38 references indexed in Scilit:
- DNMT and HDAC inhibitors together abrogate endotoxemia mediated macrophage death by STAT3-JMJD3 signalingThe International Journal of Biochemistry & Cell Biology, 2018
- Myeloid Kdm6b deficiency results in advanced atherosclerosisAtherosclerosis, 2018
- JMJD3 is involved in neutrophil membrane proteinase 3 overexpression during the hyperinflammatory response in early sepsisInternational Immunopharmacology, 2018
- Regulation of alveolar macrophage death in acute lung inflammationRespiratory Research, 2018
- Mitofusin 1 and optic atrophy 1 shift metabolism to mitochondrial respiration during agingAging Cell, 2017
- The Roles of Histone Demethylase UTX and JMJD3 (KDM6B) in Cancers: Current Progress and Future PerspectivesCurrent Medicinal Chemistry, 2016
- JMJD3 as an epigenetic regulator in development and diseaseThe International Journal of Biochemistry & Cell Biology, 2015
- The Histone Lysine Demethylase JMJD3/KDM6B Is Recruited to p53 Bound Promoters and Enhancer Elements in a p53 Dependent MannerPLOS ONE, 2014
- Mortality in sepsis versus non-sepsis induced acute lung injuryCritical Care, 2009
- High-Resolution Profiling of Histone Methylations in the Human GenomeCell, 2007